Investment Rating - The report maintains a "Buy" rating for the company, citing its leading position in the special steel industry and improving capacity integration capabilities [3][5]. Core Views - The company reported a year-on-year increase in net profit for Q1 2025, with a net profit of 1.384 billion yuan, up 1.76% year-on-year and 7.31% quarter-on-quarter, indicating a recovery in profitability [1][3]. - The demand for special steel is expected to grow in the long term due to favorable manufacturing policies and the maturation of the steel industry, leading to an anticipated recovery in sales gross margins [1][3]. - The company aims to achieve a steel production target of 18.6 million tons and an export target of 2.65 million tons in 2025, reflecting a year-on-year growth of 20.3% in exports [2][3]. Financial Performance - In Q1 2025, the company achieved operating revenue of 26.84 billion yuan, a decrease of 5.59% year-on-year, while the gross profit margin showed signs of improvement [1]. - The company's sales gross margins for the last four quarters were 12.30%, 12.51%, 14.39%, and 13.82%, indicating a gradual recovery in profitability [1]. - The projected net profits for 2025 to 2027 are 5.449 billion yuan, 5.969 billion yuan, and 6.305 billion yuan, respectively, with corresponding P/E ratios of 10.8, 9.9, and 9.4 [3][4].

证券研究报告 | 年报点评报告 gszqdatemark 2025 04 19 年 月 日 怡和嘉业（301367.SZ） 海外去库存影响消退，看好 2025 年恢复性增长 怡和嘉业发布 2024 年年度报告。2024 年实现营业收入 8.43 亿元，同比 下滑 24.85%；归母净利润 1.55 亿元，同比下滑 47.74%；扣非后归母净 利润 0.92 亿元，同比下滑 61.79%。分季度看，2024Q4 实现营业收入 2.41 亿元，同比增长 36.29%；归母净利润 3026 万元，同比增长 12.65%；扣 非后归母净利润 697 万元，同比下滑 40.22%。 | 财务指标 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入（百万元） | 1,122 | 843 | 1,053 | 1,264 | 1,511 | | 增长率 yoy（%） | -20.7 | -24.9 | 24.9 | 20.0 | 19.6 | | 归母净利润（百万元） | 297 | 155 | 198 ...

Investment Rating - The report maintains a "Buy" rating for the company [4] Core Views - The company achieved a revenue of 1.29 billion yuan in Q1 2025, with year-on-year growth of 21% and a net profit of 160 million yuan, reflecting a significant year-on-year increase of 105% [1] - The growth in performance is attributed to the continuous increase in demand for new energy products and effective cost reduction measures [1] - The company has accelerated its screw rod business layout, with successful development of new products and acquisition of technology to reduce equipment costs [2] Financial Performance Summary - Revenue projections for 2025-2027 are 5.55 billion yuan, 6.86 billion yuan, and 8.08 billion yuan respectively, with corresponding P/E ratios of 50, 41, and 35 [2] - The company’s gross margin in Q1 2025 was 21.6%, an increase of 0.6 percentage points year-on-year, while the expense ratio decreased by 2.3 percentage points [1] - The net profit for 2025 is estimated to be 555 million yuan, with a year-on-year growth rate of 11.7% [3] Business Development Summary - The company has developed a clear technical path for its screw rod business, with several products expected to enter mass production in 2025 [2] - The acquisition of Wuxi Kezhixin in February 2025 is expected to significantly reduce equipment costs and delivery times [2] - Key product milestones include the mass production of automotive screw rods in H2 2025 and the delivery of robot-related components by April 2025 [2]

Investment Rating - The investment rating for the company is "Buy (Maintain)" [5] Core Views - The company has demonstrated strong pricing power, with special gases potentially offering surprises, and a dividend yield of 5.5% [10] - The company reported a revenue of 22.05 billion yuan for 2024, a year-on-year decrease of 17.01%, while the net profit attributable to shareholders increased by 28.93% to 1.684 billion yuan [1][10] - The company is actively expanding its clean energy business and has a robust asset advantage in energy operations and logistics [2][3] Revenue and Profitability - In Q4 2024, the company achieved a revenue of 4.999 billion yuan, down 28.86% year-on-year, with a net profit of 149 million yuan, a decrease of 14.78% [1] - For Q1 2025, the company reported a revenue of 5.484 billion yuan, down 13.41% year-on-year, and a net profit of 506 million yuan, up 5.40% [1] Business Segments - The special gases business saw rapid growth, with production and sales of 8,805 million cubic meters in 2024, a year-on-year increase of 66.5% [4] - The LNG business produced and sold 2.58 million tons in 2024, with a year-on-year increase of 11.1% in production and 12.8% in sales [10] - The LPG business experienced a slight decline, with production and sales of 1.85 million tons, down 3.5% and 3.7% respectively [10] Financial Metrics - The company plans to distribute a total cash dividend of 780 million yuan for 2024, which includes a special cash dividend of 30 million yuan, representing approximately 52% of the net profit attributable to shareholders [10] - The projected net profit for 2025-2027 is estimated at 1.78 billion, 1.99 billion, and 2.18 billion yuan respectively, with corresponding P/E ratios of 9.0X, 8.1X, and 7.4X [10][11]

证券研究报告 | 年报点评报告 gszqdatemark 2025 04 18 年 月 日 九丰能源（605090.SH） 顺价能力久经考验，特种气体或存惊喜，股息率 5.5% 公司发布 2024 年年度&2025 年一季度业绩公告。2024 年公司实现营业 收入 220.47 亿元，同比下降 17.01%；归母净利润 16.84 亿元，同比增长 28.93%；扣非归母净利润 13.50 亿元，同比增长 1.12%。其中，24Q4 实 现营业收入 49.99 亿元，同比下降 28.86%；归母净利润 1.49 亿元，同比 下降 14.78%。2025 年 Q1 公司实现营业收入 54.84 亿元，同比下降 13.41%；归母净利润 5.06 亿元，同比增长 5.40%；扣非归母净利润 4.68 亿元，同比增长 1.38%。 清洁能源业务持续稳健布局。 能源作业&物流业务核心资产优势突出。 特种气体业务快速增长。2024 年公司特种气体（氦气及氢气等）产/销量 8805/8805 万方，同比+66.5%/66.5%。 ➢ 氦气业务方面，2024 年公司高纯度氦气业务（产）销量约 38 万方， 同比稳步增长。下游 ...

Investment Rating - The report maintains a "Buy" rating for the company [4] Core Views - The company achieved a significant year-on-year revenue growth of 21% in Q1 2025, reaching 1.29 billion yuan, with a net profit of 160 million yuan, reflecting a 105% increase [1] - The growth is attributed to the continuous demand in the new energy sector and effective cost reduction strategies, enhancing overall profitability [1] - The company has accelerated its screw rod business layout, with successful product development and production line completion expected in 2025 [2] Financial Performance Summary - Revenue projections for 2025-2027 are 5.55 billion yuan, 6.86 billion yuan, and 8.08 billion yuan, respectively, with corresponding P/E ratios of 50, 41, and 35 [2] - The company’s gross margin improved to 21.6% in Q1 2025, up 0.6 percentage points year-on-year, while the expense ratio decreased by 2.3 percentage points [1] - The net profit for 2025 is estimated at 555 million yuan, with a year-on-year growth rate of 11.7% [3] Business Development Summary - The company has developed a clear technical path for its screw rod business, with several products expected to enter mass production in 2025 [2] - The acquisition of Wuxi Kezhixin in February 2025 is anticipated to significantly reduce equipment costs and delivery times [2] - Key milestones include the planned mass production of automotive screw rods in H2 2025 and the delivery of robot-related products by April 2025 [2]

证券研究报告 | 年报点评报告 gszqdatemark 2025 04 18 年 月 日 天山铝业（002532.SZ） 2024 年利润创历史新高，30%高分红承诺凸显长期投资价值 事件：公司发布 2024 年年报及 2025 年一季报业绩预告。2024 年公司实 现收入 280.89 亿元，同比-3%，归母净利 44.55 亿元，同比+102%。分 季度看， 24Q1-Q4 公司实现营收 68/70/70/73 亿元， Q4 同环比 +10%/+4% ； 归 母 净 利 7.2/13.5/10.1/13.7 亿元， Q4 同环比 +141%/+36%；25Q1 预计实现归母净利 10.5 亿元，同环比+46%/-23%。 25Q1 利润环比减少我们判断主要系电解铝和氧化铝价格环比下降所致。 铝产品"量价齐升"24 年利润创历史新高。1）量：2024 年全年电解铝 产量 117.59 万吨，同比增加约 1%；氧化铝产量 227.89 万吨，同比增加 7.55%；公司自发电机组运行良好，全年发电超 138 亿度，同比增加约 2.5%；阳极碳素产量 54.89 万吨，同比减少 8.35%；加工板块方面，高 纯 ...

证券研究报告 | 年报点评报告 gszqdatemark 2025 04 18 年 月 日 原料/医疗终端业务稳健同增 9.47%/32.03%，皮肤科学创新转化业务承压。 2024 年分业务板块来看： 1）原料业务：实现收入 12.36 亿元（yoy+9.47%），其中国际市场原料实现收入 6.08 亿元（yoy+17.65%），美洲、欧洲、东南亚等地销售收入同比增长均超过 20%。 毛利率方面，原料业务（不含弗思特）整体毛利率为 65.57%，同比+0.86pcts， 医药级透明质酸原料毛利率为 87.56%。公司原料产品不断丰富，2024 年进行原 料及合成生物研发项目 96 个，10 种生物活性物原料新产品完成上市。 2）医疗终端业务：实现收入 14.40 亿元（yoy+32.03%），毛利率同比+2.27pcts 至 84.37%，医美业务变革效果显著，运营能力提升，费用率稳步下降。皮肤类医 疗产品实现收入 10.73 亿元（yoy+43.57%），公司医美机构覆盖数量为 7000 家， 同增 30%+。其中差异化优势品类微交联润致娃娃针收入同增 100%+，覆盖机构 数量超 5000 家；坚持产品 ...

Investment Rating - The investment rating for the company is "Buy" [6] Core Views - The company is expected to achieve a record profit in 2024, with a commitment to a high dividend payout of 30% over the next three years, highlighting its long-term investment value [3] - The company reported a revenue of 28.089 billion yuan in 2024, a decrease of 3% year-on-year, while the net profit attributable to shareholders reached 4.455 billion yuan, an increase of 102% year-on-year [1][2] Summary by Sections Financial Performance - In 2024, the company achieved an electrolytic aluminum production of 1.1759 million tons, a year-on-year increase of approximately 1%, and alumina production of 2.2789 million tons, an increase of 7.55% [2] - The average selling price of self-produced electrolytic aluminum was approximately 19,800 yuan per ton, a year-on-year increase of 6%, while the average selling price of self-produced alumina was about 4,000 yuan per ton, a year-on-year increase of 40% [2] - The company’s production costs for electrolytic aluminum and alumina increased by 4% and 2% year-on-year, respectively, but the increase in selling prices significantly outpaced the cost increases, leading to substantial profit growth [2] Dividend Policy - The company distributed a total cash dividend of 1.845 billion yuan in 2024, with a dividend payout ratio of 41.42% and a dividend yield of 5.55% [3] - The company has announced a shareholder return plan for 2025-2027, committing to a cash dividend ratio of no less than 30% of the annual net profit [3] Future Outlook - The company aims for a production target of 1.16 million tons of primary aluminum and 2.4 million tons of alumina in 2025, with a focus on enhancing resource security through overseas acquisitions and domestic mining [2] - The projected net profit attributable to shareholders for 2025-2027 is expected to be 4.8 billion, 5.5 billion, and 6.0 billion yuan, respectively, with corresponding P/E ratios of 6.9, 6.0, and 5.5 times [3]

Investment Rating - The report maintains a "Buy" rating for the company [7] Core Views - The company is experiencing a phase of operational pressure, with expectations for gradual improvements from management reforms and strategic investments [1] - Revenue for 2024 is projected at 5.371 billion yuan, a year-over-year decrease of 11.61%, while net profit is expected to be 174 million yuan, down 70.59% year-over-year [1] - The company is positioned as a biotechnology materials platform, with potential for steady growth across its diversified business segments as management reforms take effect [5] Business Segment Summaries Raw Material Business - Revenue reached 1.236 billion yuan, an increase of 9.47% year-over-year, with international markets contributing 608 million yuan, up 17.65% [2] - The overall gross margin for the raw material business was 65.57%, a slight increase of 0.86 percentage points [2] Medical Terminal Business - Revenue for this segment was 1.440 billion yuan, reflecting a significant growth of 32.03% year-over-year, with a gross margin of 84.37% [3] - The aesthetic medicine business showed notable improvement, with skin-related medical products generating 1.073 billion yuan, up 43.57% [3] Skin Science Innovation Business - This segment reported revenue of 2.569 billion yuan, a decline of 31.62% year-over-year, with a gross margin of 72.80% [4] - The company is focusing on product innovation in skin repair and anti-aging, with new product launches aimed at enhancing competitive positioning [4] Nutritional Science Innovation Business - Revenue in this area was 82 million yuan, marking a growth of 40.97% year-over-year, focusing on key areas such as nutrition and immunity [4] Financial Forecasts and Investment Recommendations - Revenue projections for 2025-2027 are set at 5.848 billion yuan, 6.522 billion yuan, and 7.387 billion yuan, representing year-over-year growth rates of 8.9%, 11.5%, and 13.3% respectively [5] - Net profit forecasts for the same period are 469 million yuan, 624 million yuan, and 778 million yuan, with significant growth anticipated in 2025 at 169.2% [5]